Literature DB >> 8904592

Terbutaline stimulates alveolar fluid resorption in hyperoxic lung injury.

J M Lasnier1, O D Wangensteen, L S Schmitz, C R Gross, D H Ingbar.   

Abstract

Alveolar fluid resorption occurs by active epithelial sodium transport and is accelerated by terbutaline in healthy lungs. We investigated the effect of terbutaline on the rate of alveolar fluid resorption from rat lungs injured by hyperoxia. Rats exposed to > 95% O2 for 60 h, sufficient to increase wet-to-dry lung weight and cause alveolar edema, were compared with air-breathing control rats. After anesthesia, the animals breathed 100% O2 for 10 min through a tracheostomy. Ringer solution was instilled into the alveoli, and the steady-state rate of volume resorbed at 6 cmH2O pressure was measured via a pipette attached to the tracheostomy tubing. Ringer solution in some animals contained terbutaline (10(-3) M), ouabain (10(-3) M), or both. Normoxic animals resorbed 49 +/- 6 microliters.kg-1.min-1; ouabain reduced this by 39%, whereas terbutaline increased the rate by 75%. The effect of terbutaline was blocked by ouabain. Hyperoxic animals absorbed 78 +/- 9 microliters.kg-1.min-1; ouabain reduced this by 44%. Terbutaline increased the rate by a mean of 39 microliters.kg-1.min-1, similar to the absolute effect seen in the normoxic group, and this was blocked by ouabain. Terbutaline accelerates fluid resorption from both normal and injured rat lungs via its effects on active sodium transport.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8904592     DOI: 10.1152/jappl.1996.81.4.1723

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  13 in total

Review 1.  Treatment of adult respiratory distress syndrome: plea for rescue therapy of the alveolar epithelium.

Authors:  Y Berthiaume; O Lesur; A Dagenais
Journal:  Thorax       Date:  1999-02       Impact factor: 9.139

2.  Hypoxia induced changes in lung fluid balance in humans is associated with beta-2 adrenergic receptor density on lymphocytes.

Authors:  Micah W Johnson; Bryan J Taylor; Minelle L Hulsebus; Bruce D Johnson; Eric M Snyder
Journal:  Respir Physiol Neurobiol       Date:  2012-07-03       Impact factor: 1.931

Review 3.  Biomarkers in pediatric acute respiratory distress syndrome.

Authors:  Erin F Carlton; Heidi R Flori
Journal:  Ann Transl Med       Date:  2019-10

4.  Ventilation following established ARDS: a preclinical model framework to improve predictive power.

Authors:  Charlotte Oakley; Marissa Koh; Rhianna Baldi; Sanooj Soni; Kieran O'Dea; Masao Takata; Michael Wilson
Journal:  Thorax       Date:  2019-07-05       Impact factor: 9.139

5.  Physiological and biochemical markers of alveolar epithelial barrier dysfunction in perfused human lungs.

Authors:  James A Frank; Raphael Briot; Jae Woo Lee; Akitoshi Ishizaka; Tokujiro Uchida; Michael A Matthay
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-03-09       Impact factor: 5.464

Review 6.  Pharmacotherapy of acute lung injury and the acute respiratory distress syndrome.

Authors:  Magda Cepkova; Michael A Matthay
Journal:  J Intensive Care Med       Date:  2006 May-Jun       Impact factor: 3.510

7.  Clinical Acute Lung Injury and Acute Respiratory Distress Syndrome.

Authors:  Michael A. Matthay; Tokujiro Uchida; Xiaohui Fang
Journal:  Curr Treat Options Cardiovasc Med       Date:  2002-04

8.  Triiodo-L-thyronine rapidly stimulates alveolar fluid clearance in normal and hyperoxia-injured lungs.

Authors:  Maneesh Bhargava; Marie R Runyon; Dmitri Smirnov; Jianxun Lei; Thomas J Groppoli; Cary N Mariash; O Douglas Wangensteen; David H Ingbar
Journal:  Am J Respir Crit Care Med       Date:  2008-06-12       Impact factor: 21.405

9.  Inhaled beta-2 agonist salbutamol and acute lung injury: an association with improvement in acute lung injury.

Authors:  Sanjay Manocha; Anthony C Gordon; Ebrahim Salehifar; Horacio Groshaus; Keith R Walley; James A Russell
Journal:  Crit Care       Date:  2006-02       Impact factor: 9.097

10.  Inhibition of inflammatory responses by ambroxol, a mucolytic agent, in a murine model of acute lung injury induced by lipopolysaccharide.

Authors:  Xiao Su; Ling Wang; Yuanlin Song; Chunxue Bai
Journal:  Intensive Care Med       Date:  2003-09-20       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.